Non-autoimmune haemostasis disorders associated with spontaneous foetal losses;Anomalies non auto-immunes de l'hemostase et echecs spontanes de grossesses

Sang Thrombose Vaisseaux

Volumn 12, Issue 5, 2000, Pages 305-313

  Gris, Jean Christophe ^a   Mares, Pierre ^a  

^a NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN;

AUTOIMMUNE DISEASE; BLOOD CLOTTING DISORDER; EMBRYO DEVELOPMENT; FETUS DEATH; GENE MUTATION; HEMOSTASIS; HETEROZYGOSITY; HIGH RISK PATIENT; HUMAN; REVIEW; SPONTANEOUS ABORTION; THROMBOCYTHEMIA; THROMBOPHILIA; THROMBOSIS;

EID: 0033947371     PISSN: 09997385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Lockshin MD. Pregnancy loss in the antiphospholipid syndrome. Thromb Haemost 1999 ; 82 : 641-8.
2. Evron S, Auteby SO, Brzezinssky A. Congenital afibrinogenemia and recurrent abortion : a case report. Eur J obstet Biol 1985 ; 19 : 307-11.
3. Aznar J, Fernandez-Pla MA, Aznar JA. Congenital hypofibrinogenemia in tree of a family. Coagulation 1972 ; 3 : 279-84.
4. Hahn L, Lundberg PA. Congenital hypofibrinogenemia and recurrent abortion. Case report. Br J Obstet Gynaecol 1978 ; 85 : 790-3.
5. Kitchens CS, Cruz AC, Kant JA. A unique 7p/12q chromosomal abnormality associated with recurrent abortion and hypofibrinogenemia. Blood 1987 ; 70 . 921-5.
6. Duckert F The fibrin stabilizing factor, factor XIII. Blut 1973 ; 26 : 177-9.
7. Berliner S, Lusky A, Zivelin A. Hereditary factor XIII deficiency : report of four families and definition of carrier. Br J Haematol 1984 ; 56 : 495-505.
8. Rodeghiero F, Castaman GC, di Bona E. Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Blut 1987 ; 55 : 45-8.
9. Kobayashi T, Terano T, Kojima T. Congenital factor XIII deficiency, treatment with factor XIII concentrate and normal vaginal delivery. Gynecol Obstet Invest 1990 ; 29 : 235-8.
10. Girolami A, Cappelato MG, Lazzaro AR Type I and type II disease in congenital factor XIII deficiency. Blut 1986 ; 53 : 411-3.
11. Soria J, Soria C, Samama MM. Fibrinogen Troyes, fibrinogen Metz. Two new cases of congenital dysfibrinogenemia. Thromb Diath Haemorrh 1972 ; 27 619-24.
12. Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC subcommittee on fibrinogen. Thromb Haemost 1995 ; 73 : 151-61.
13. Griesshammer M, Heimpel H, Pearson TC. Essential thrombocythemia and pregnancy. Leuk Lymphoma 1996 ; 22 (suppl. 1) : 57-63.
14. Sanson BJ, Friederick PW, Simioni P, et al. The risk of abortion and stillbirth in antithrombin- protein C- and protein S-deficient women. Thromb Haemost 1996 ; 75 : 387-8.
15. Preston FF, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia Lancet 1996 ; 348 : 913-6.
16. Trott EA, Russel JB. Plouffet L Jr. A review of the genetics of recurrent pregnancy loss. Del Med J 1996 ; 68 : 495-8.
17. Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost 1999 ; 82 : 610-9.
18. Rai R, Regan L, Hadley E, Dave M, Cohen H. Second-trimester pregnancy loss is associated with activated protein C resistance. Br J Haematol 1996 ; 92 : 489-90.
19. Rai RS. Regan L. Chitolie A, Donald JG, Cohen H Placental thrombosis and second trimester miscarriages in association with activated protein C resistance. Br J Obset Gynaecol 1996; 103 : 842-4.
20. Gris JC, Ripart-Neveu S, Maugard C, et al. Prospective evaluation of the prevalence of haemostasia abnormalities in unexplained primary eraly recurrent miscarriages. Thromb Haemost 1997 ; 77 : 1096-103.
21. Grandone E, Matgaglione M, Colaizzo D, et al. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997 ; 77 : 822-4.
22. Brenner B, Mandel H, Lanir N, et al Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol 1997 ; 97 : 551-4.
23. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Throimbophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999 , 82 : 6-9.
24. Ridker PM, Miletich JP, Buring JE, et al. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med 1998 ; 128 : 1000-3.
25. Coumans AB, Huijgens PC, Jakobs C, et al. Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion. Hum Reprod 1999 ; 14 : 211-4.
26. Kutteh WH, Park VM, Peitcher JR. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril 1999 ; 71 : 1048-53.
27. Menardi JR, Middeldorp S, de Kam PJ, et al. Increased risk for fetal loss in carriers of the factor V Leiden mutation. Ann Intern Med 1999 ; 130 : 736-9.
28. Tal J, Schliamser LM, Leibovitz Z, Ohel G, Attias D. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure. Hum Reprod 1999 ; 14 : 1624-7.
29. Gris JC, Quéré I, Montpeyroux F, et al. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent. Thromb Haemost 1999 ; 81 : 891-9.
30. Tormene D, Simioni P, Prandoni P, et al. The risk of fetal loss in family members of probands with factor V Leiden mutation. Thromb Haemost 1999 ; 82 : 1237-9.
31. Alhenc-Gelas M, Arnaud E, Nicaud V, et al. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thromb Haemost 1999 ; 81 : 506-10.
32. Molloy AM, Daly S, Mills JL, et al. Thermolabile variant of 5,10-methylene-tetrahydrofolate reductase associated with low red-cell folates : implications for folate intake recommendations. Lancet 1977 ; 349 : 1591-3.
33. Quéré I, Wutschert R, Zittoun J, et al. Association of red-blood methylfolate but not plasma folate with C677T polymorphism in venous thromboembolic disease. Thromb Haemost 1998 ; 80 : 707-9.
34. Pickering W, Holmes Z, Regan L, Cohen H. Normal prevalence of the G20210A prothrombin gene mutation in women with recurrent miscarriage. Br J Haematol 1998 ; 102 (suppl. 1): 250.
35. Souza SS, Ferriani RA, Pontes AG, Zago MA, Franco RF. Factor v Leiden and factor II G20210A mutations in patients with recurrent abortion. Hum Reprod 1999 ; 14: 2448-50.
36. Holmes ER, Regan L, Chilcott I, Cohen H. The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. Br J Haematol 1999 ; 105 : 98-101.
37. Nelen WL, Blom HJ, Thomas CM, Steegers EA, Boers CH, Eskes TK. Methylene tetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr 1998 ; 1208 : 1336-41.
38. Gris JC, Schved JF, Neveu S, Marès P, Aguilar-Martinez P, Dupaigne D. Impaired fibrinolytic capacity and early recurrent spontaneous abortion. Br Med J 1990 ; 300 : 1500.
39. Gris JC, Neveu S, Marès P, Biron C, Hédon B, Schved JF. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. J Lab Clin Med 1993 ; 122 : 606-15
40. Thomson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW, for the ECAT. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995 ; 332 : 635-41.
41. Wilkenstein W Jr, Stenchever MA, Lilienfield AM. Occurrence of pregnancy, abortion and artificial menopause among women with coronary heart disease. J Chron Dis 1958 ; 7 : 273-86
42. Gris JC, Neveu S, Tailland ML, Courtieu C, Marès, P, Schved JF. Use of a low-molecular weight heparin (enoxaparin) or of a phenformin-like substance (moroxydine chloride) in primary early recurrent aborters with an impaired fibrinolytic capacity. Thromb Haemost 1995 ; 73 : 362-7.